Showing results (181-190 of 204) with videos related to
Sort By:
Pageof 21
The International Journal of Biological Markers|June 8, 2018
Plasma cholesterol and lipoprotein levels in relation to tumor aggressiveness and survival in HCC patientsBrian I Carr, Gianluigi Giannelli, Vito Guerra, et al.The International Journal of Biological Markers|May 17, 2014
Low alpha-fetoprotein HCC and the role of GGTPBrian I Carr, Vito Guerra, Edoardo G Giannini, et al.Hepato-Gastroenterology|March 13, 2013
Single-center analysis of the first 304 living-donor liver transplantations in 3 yearsSezai Yilmaz, Cuneyt Kayaalp, Cengiz Ara, et al.Hepatology (Baltimore, Md.)|November 22, 2007
Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosisLaura M Kulik, Brian I Carr, Mary F Mulcahy, et al.International Journal of Clinical Practice|June 26, 2020
Serum levels of inflammatory markers CRP, ESR and albumin in relation to survival for patients with hepatocellular carcinomaHikmet Akkiz, Brian I Carr, Harika G Bag, et al.Cancer|July 27, 2012
Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinomaHan Chong Toh, Pei-Jer Chen, Brian I Carr, et al.Hepatology Forum|January 29, 2024
Changing trends in the etiology of liver transplantation in Turkiye: A multicenter studyMesut Akarsu, Suleyman Dolu, Murat Harputluoglu, et al.Hepatology Forum|May 30, 2023
First year real life experience with tenofovir alafenamide fumarate: The pythagorean cohortOmer Karasahin, Irem Akdemir Kalkan, Tuba Dal, et al.Journal of Hepatology|September 29, 2016
The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinomaDavid J Pinato, Rohini Sharma, Elias Allara, et al.Hepatology Forum|October 12, 2023
The efficacy and tolerability of glecaprevir/pibrentasvir treatment in a real-world chronic hepatitis C patients cohortSerkan Yaras, Mehmet Demir, Sezgin Barutcu, et al.Pageof 21